The prevalence of patients suffering from chronic spontaneous urticaria, in whom omalizumab cannot be stopped even after six years
- DOI
- 10.3389/falgy.2024.1464466
- Published
- 2024-10-02
- Container
- Frontiers in Allergy
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/falgy.2024.1464466,
title = {The prevalence of patients suffering from chronic spontaneous urticaria, in whom omalizumab cannot be stopped even after six years},
author = {V. Schichter-Konfino and R. Mubariki and E. Toubi and Z. Vadasz},
year = {2024},
journal = {Frontiers in Allergy},
doi = {10.3389/falgy.2024.1464466},
url = {https://doi.org/10.3389/falgy.2024.1464466}
}RIS
TY - JOUR TI - The prevalence of patients suffering from chronic spontaneous urticaria, in whom omalizumab cannot be stopped even after six years AU - V. Schichter-Konfino AU - R. Mubariki AU - E. Toubi AU - Z. Vadasz PY - 2024 JO - Frontiers in Allergy DO - 10.3389/falgy.2024.1464466 UR - https://doi.org/10.3389/falgy.2024.1464466 ER -
APA
Schichter-Konfino, V., Mubariki, R., Toubi, E., & Vadasz, Z. (2024). The prevalence of patients suffering from chronic spontaneous urticaria, in whom omalizumab cannot be stopped even after six years. Frontiers in Allergy. https://doi.org/10.3389/falgy.2024.1464466
Source records
- crossref · retrieved 2026-11-10T15:55:44.641Z